Syri Pharma Limited t/a Thame Laboratories — 23 Licensed Medicines in Ireland

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

← All medicines · 23 products held by Syri Pharma Limited t/a Thame Laboratories

Medicine	Active substance	Licence holder	Status
Aciclovir 200 mg/5ml Oral Suspension PA22697/001/001	Aciclovir	Syri Pharma Limited t/a Thame Laboratories	Marketed
Aciclovir 400 mg/5ml Oral Suspension PA22697/001/002	Aciclovir	Syri Pharma Limited t/a Thame Laboratories	Not marketed
Amitriptyline hydrochloride 10 mg/5 ml Oral Solution PA22697/002/001	Amitriptyline hydrochloride	Syri Pharma Limited t/a Thame Laboratories	Not marketed
Amitriptyline hydrochloride 25 mg/5 ml Oral Solution PA22697/002/002	Amitriptyline hydrochloride	Syri Pharma Limited t/a Thame Laboratories	Not marketed
Amitriptyline hydrochloride 50 mg/5 ml Oral Solution PA22697/002/003	Amitriptyline hydrochloride	Syri Pharma Limited t/a Thame Laboratories	Not marketed
Amlodipine Thame 10 mg/5 ml Oral Solution PA22697/003/002	Amlodipine	Syri Pharma Limited t/a Thame Laboratories	Not marketed
Amlodipine Thame 5mg/5ml Oral Solution PA22697/003/001	Amlodipine	Syri Pharma Limited t/a Thame Laboratories	Not marketed
Baclofen 5 mg/5 ml oral solution PA22697/005/001	Baclofen	Syri Pharma Limited t/a Thame Laboratories	Not marketed
Bisoprolol Syri Pharma 0.5 mg/ml PA22697/019/001	BISOPROLOL FUMARATE	Syri Pharma Limited t/a Thame Laboratories	Not marketed
Clobazam Thame 10 mg/5 ml Oral Suspension PA22697/006/002	Clobazam	Syri Pharma Limited t/a Thame Laboratories	Not marketed
Clobazam Thame 5 mg/5 ml Oral Suspension PA22697/006/001	Clobazam	Syri Pharma Limited t/a Thame Laboratories	Not marketed
Clonidine hydrochloride 100 micrograms/ 5 ml Oral Solution PA22697/020/001	Clonidine hydrochloride	Syri Pharma Limited t/a Thame Laboratories	Not marketed
Diazepam 0.4 mg/ml oral suspension PA22697/022/001	Diazepam	Syri Pharma Limited t/a Thame Laboratories	Not marketed
Fluoxetine 20 mg/ 5 ml Oral Solution PA22697/010/001	FLUOXETINE HYDROCHLORIDE	Syri Pharma Limited t/a Thame Laboratories	Marketed
Gabapentin Thame 50 mg/ml oral solution PA22697/025/001	Gabapentin	Syri Pharma Limited t/a Thame Laboratories	Marketed
Kay-Cee-L Syrup 7.5% w/v PA22697/026/001	Potassium chloride	Syri Pharma Limited t/a Thame Laboratories	Marketed
Lamotrigine SyriMed 5mg/ml Oral Suspension PA22697/018/001	Lamotrigine	Syri Pharma Limited t/a Thame Laboratories	Not marketed
Levetiracetam Thame 100 mg/ml oral solution PA22697/012/001	Levetiracetam	Syri Pharma Limited t/a Thame Laboratories	Marketed
Ondansetron 4 mg/5 ml syrup PA22697/013/001	Ondansetron	Syri Pharma Limited t/a Thame Laboratories	Marketed
Sodium chloride 5 mmol/ml Oral Solution PA22697/015/001	Sodium chloride	Syri Pharma Limited t/a Thame Laboratories	Not marketed
Syrisal 1 mmol/ml oral solution PA22697/016/001	Sodium chloride	Syri Pharma Limited t/a Thame Laboratories	Marketed
Thamicarb 84 mg/ml Oral Solution PA22697/017/001	Sodium hydrogen carbonate	Syri Pharma Limited t/a Thame Laboratories	Marketed
Tolterodine tartrate 0.4 mg/ml oral suspension PA22697/021/001	Tolterodine tartrate	Syri Pharma Limited t/a Thame Laboratories	Not marketed

Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 21 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.

Syri Pharma Limited t/a Thame Laboratories — Licensed Medicines